First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Supermax Corporation Berhad: the story is balanced — Global glove demand trends driven by healthcare utilization rates and infection control protocols (normalized post-COVID…
★ Analysts see FY2027 revenue reaching $989M — +18.0% growth in a single year.
What Moves the Stock
1Global glove demand trends driven by healthcare utilization rates and infection control protocols (normalized post-COVID to 2019 baseline plus 10-15% structural growth)
2Natural rubber latex spot prices (SICOM TSR20 benchmark) and nitrile butadiene rubber costs, which represent 35-40% of COGS and fluctuate with crude oil derivatives
3Capacity rationalization announcements from major producers (Top Glove, Hartalega, Kossan) indicating supply discipline or further expansion
4Average selling price (ASP) trends in key markets - prices declined 60-70% from 2021 peaks to current $25-35 per 1,000 gloves for nitrile examination gloves
5Malaysian ringgit exchange rate movements affecting USD-denominated revenue translation and competitiveness versus Thai/Chinese producers
value/distressed - The 0.2x price/book and negative FCF profile attracts deep value investors betting on cyclical recovery and asset value…
Rising interest rates create moderate pressure through two channels: (1) increased financing costs on working capital facilities used…
Watch on earnings: SICOM TSR20 natural rubber latex spot price (Singapore Commodity Exchange benchmark), Nitrile butadiene rubber (NBR) contract prices correlated to crude oil and butadiene feedstock costs, US FDA medical device import data for examination glove volumes and unit values (proxy for ASP trends).
One Sentence Summary:
Supermax Corporation Berhad: the story is balanced — global glove demand trends driven by healthcare utilization rates and infection control protocols (normalized post-covid to 2019 baseline.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.